Drug safety - JoVE Visualize

Showing results (371-380 of 3,079) with videos related to

Pageof 308

Sort By:

Drug Safety|February 1, 1994

A risk-benefit appraisal of drugs used in the management of premenstrual syndromeJ F Mortola

Drug Safety|February 1, 1994

Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugsL R Willett, J L Carson, B L Strom

Drug Safety|February 1, 1994

Withdrawal phenomena associated with antidepressant and antipsychotic agentsS C Dilsaver

Drug Safety|October 1, 1993

Adverse reactions with beta-adrenoceptor blocking drugs. An updateR V Lewis, C Lofthouse

Drug Safety|November 1, 1994

Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunctionR I Henkin

Drug Safety|October 26, 2006

Bias due to false-positive diagnoses in an automated health insurance claims databaseStephan F Lanes, Cynthia de Luise

Drug Safety|July 1, 2006

Use of the dose, time, susceptibility (DoTS) classification scheme for adverse drug reactions in pharmacovigilance planningTorbjörn Callréus

Drug Safety|June 1, 2007

Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety: a review of the current literatureIndra Chedoe, Harry A Molendijk, Suzanne T A M Dittrich, et al.

Drug Safety|June 1, 2007

Surveillance of prescription drug-related mortality using death certificate dataDiane K Wysowski

Drug Safety|May 3, 2007

Widespread hyoscine hydrobromide toxicity due to contract manufacturer malpractice : the travacalm episodeJohn McEwen, Barry R Thompson, Patrick M Purcell, et al.

Pageof 308

Showing results (371-380 of 3,079) with videos related to

Sort By:

Pageof 308

Drug Safety|February 1, 1994

A risk-benefit appraisal of drugs used in the management of premenstrual syndromeJ F Mortola

Drug Safety|February 1, 1994

Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugsL R Willett, J L Carson, B L Strom

Drug Safety|February 1, 1994

Withdrawal phenomena associated with antidepressant and antipsychotic agentsS C Dilsaver

Drug Safety|October 1, 1993

Adverse reactions with beta-adrenoceptor blocking drugs. An updateR V Lewis, C Lofthouse

Drug Safety|November 1, 1994

Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunctionR I Henkin

Drug Safety|October 26, 2006

Bias due to false-positive diagnoses in an automated health insurance claims databaseStephan F Lanes, Cynthia de Luise

Drug Safety|July 1, 2006

Use of the dose, time, susceptibility (DoTS) classification scheme for adverse drug reactions in pharmacovigilance planningTorbjörn Callréus

Drug Safety|June 1, 2007

Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety: a review of the current literatureIndra Chedoe, Harry A Molendijk, Suzanne T A M Dittrich, et al.

Drug Safety|June 1, 2007

Surveillance of prescription drug-related mortality using death certificate dataDiane K Wysowski

Drug Safety|May 3, 2007

Widespread hyoscine hydrobromide toxicity due to contract manufacturer malpractice : the travacalm episodeJohn McEwen, Barry R Thompson, Patrick M Purcell, et al.

Pageof 308